170
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Application of tree-based machine learning classification methods to detect signals of fluoroquinolones using the Korea Adverse Event Reporting System (KAERS) database

, , , , & ORCID Icon
Pages 629-636 | Received 27 Oct 2022, Accepted 23 Jan 2023, Published online: 23 Feb 2023

References

  • Park S-H, Chung KH, Park BJ, et al. Educating healthcare professionals in pharmacovigilance: global trends and Korea’s status Korean Medical Education Review. 2020;22(1): 32–45 .
  • Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients a meta-analysis of prospective studies. JAMA. 1998;279(15):1200–1205.
  • Kim HR, Sung M, Park JA, et al. Analyzing adverse drug reaction using statistical and machine learning methods: a systematic review. Medicine (Baltimore). 2022 Jun 24;101(25):e29387.
  • Jang M-G, Gu H-J, Kim J, et al. Signal detection for adverse event of varenicline in Korea Adverse Event Reporting System. Korean Journal of Clinical Pharmacy. 2022;32(1):1–7.
  • Baek J-W, Yang BR, Choi S, et al. Signal Detection for adverse events of finasteride using Korea Adverse Event Reporting System (KAERS) database. Korean Journal of Clinical Pharmacy. 2021;31(4):324–331.
  • Ran J, Yang J-Y, Lee J-H, et al. Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016. Int J Clin Pharm. 2019;41(5):1365–1372.
  • Candore G, Juhlin K, Manlik K, et al. Comparison of statistical signal detection methods within and across spontaneous reporting databases. Drug Saf. 2015;38(6):577–587.*.
  • Pham M, Cheng F, Ramachandran K, et al. Study of algorithms to detect drug–adverse event associations: frequentist, Bayesian, and machine-learning approaches. Drug Saf. 2019 [2019 Jun 01];42(6):743–750.
  • Bae JH, Baek YH, Lee JE, et al. Machine learning for detection of safety signals from spontaneous reporting system data: example of nivolumab and docetaxel. Front Pharmacol. 2020;11:602365.
  • Pilipiec P, Liwicki M, Bota A. Using machine learning for pharmacovigilance: a systematic review. Pharmaceutics. 2022;14(2):266.
  • Adrover C, Bodnar T, Huang Z, et al. Identifying Adverse Effects of HIV Drug treatment and associated sentiments using twitter. JMIR Public Health and Surveillance. 2015;1(2):e7.
  • Lee CY, Chen Y-P-P. Machine learning on adverse drug reactions for pharmacovigilance. Drug Discov Today. 2019 [2019 Jul 01];24(7):1332–1343.
  • FDA. FDA updates warnings for fluoroquinolone antibiotics on risks of mental health and low blood sugar adverse reactions 2018 [28, August 2022]. Available from: https://www.fda.gov/news-events/press-announcements/fda-updates-warnings-fluoroquinolone-antibiotics-risks-mental-health-and-low-blood-sugar-adverse
  • Ellis DE, Hubbard RA, Willis AW, et al. Comparative risk of serious hypoglycemia among persons dispensed a fluoroquinolone versus a non-fluoroquinolone antibiotic. Diabetes Res Clin Pract. 2022 [2022 Mar 01];185:109225.
  • EMA. Fluoroquinolone and quinolone antibiotics: PRAC recommends new restrictions on use following review of disabling and potentially long-lasting side effects 2018 [28, Aug 2022]. Available from: https://www.ema.europa.eu/en/news/fluoroquinolone-quinolone-antibiotics-prac-recommends-new-restrictions-use-following-review
  • Huruba M, Farcas A, Leucuta DC, et al. A vigibase descriptive study of fluoroquinolone-associated peripheral nervous system disorders . Pharmaceuticals (Basel). 2022 ;Vol. 15:2.
  • Kim S, Park K, M-s K, et al. Data-mining for detecting signals of adverse drug reactions of fluoxetine using the Korea Adverse Event Reporting System (KAERS) database. Psychiatry Res. 2017;256:237–242.
  • You S-H, Kim M-S, Lee, M-T, et al. Comparison of signal detection methodologies using the Korean spontaneous adverse event reports after pneumococcal vaccination. Journal of Pharmacoepidemiology and Risk Management. 2020;12(1):44–52.
  • Raschi E, Mazzarella A, Antonazzo IC, et al. Toxicities with immune checkpoint inhibitors: emerging priorities from disproportionality analysis of the FDA adverse event reporting system. Target Oncol. 2019;14(2):205–221.
  • Lim K, Shin HT, Sohn HS, et al. Comparison of WHO-ART Versus MedDRA, internationally standardized terminology of Adverse Drug Reaction classification. Korean J Clin Pharm. 2007;17(1):46–51.
  • Song YY, Lu Y. Decision tree methods: applications for classification and prediction. Shanghai Arch Psychiatry. 2015 Apr 25;27(2):130–135.
  • Machová K, Barcak F, Bednár P. A bagging method using decision trees in the role of base classifiers. Acta Polytech Hungarica. 2006;3(2):121–132.
  • Arfiani A, Rustam Z, editors. Ovarian cancer data classification using bagging and random forest. 4th International Symposium on Current Progress in Mathematics and Sciences (ISCPMS2018); Depok, Indonesia; 2019: AIP Publishing LLC.
  • Stepanov N, Alekseeva D, Ometov A, et al., editors. Applying machine learning to LTE traffic prediction: comparison of bagging, random forest, and SVM. 2020 12th International Congress on Ultra Modern Telecommunications and Control Systems and Workshops (ICUMT); Online; 2020 5-7 Oct. 2020.
  • Mayr A, Binder H, Gefeller O, et al. The evolution of boosting algorithms. Methods Inf Med. 2014;53(6):419–427.
  • Si M, Du K. Development of a predictive emissions model using a gradient boosting machine learning method. Environ Technol Innovation. 2020;20:101028.
  • van Puijenbroek EP, Bate A, Leufkens HG, et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002 Jan-Feb;11(1):3–10.
  • Walsh I, Fishman D, Garcia-Gasulla D, et al. DOME: recommendations for supervised machine learning validation in biology. Nat Methods. 2021;18(10):1122–1127.
  • Lipton ZC, Elkan C, Narayanaswamy B. Thresholding classifiers to maximize F1 score. arXiv preprint arXiv. 2014;2:1402.1892.
  • Martin B, Finlay J, Sterling K, et al. Early detection of prostate cancer in African-American men through use of multiple biomarkers: human kallikrein 2 (hK2), prostate-specific antigen (PSA), and free PSA (fPSA). Prostate Cancer Prostatic Dis. 2004;7(2):132–137.
  • Harpaz R, DuMouchel W, LePendu P, et al. Performance of pharmacovigilance signal‐detection algorithms for the FDA adverse event reporting system. Clin Pharmacol Ther. 2013;93(6):539–546.
  • Akula R, Nguyen N, Garibay I, editors Supervised machine learning based ensemble model for accurate prediction of type 2 diabetes. Vol. 2019. SoutheastCon: IEEE; 2019.
  • Krishnani D, Kumari A, Dewangan A, et al. Prediction of Coronary Heart Disease using Supervised Machine Learning Algorithms. TENCON 2019-2019 IEEE Region 10 Conference (TENCON); Kochi, India; 2019; 2019 Oct 17-20.
  • Tu MC, Shin D, Shin D, editors. A comparative study of medical data classification methods based on decision tree and bagging algorithms. 2009 Eighth IEEE International Conference on Dependable, Autonomic and Secure Computing; Chengdu, China; 2009 12-14 Dec. 2009.
  • Jones SC, Sorbello A, Boucher RM. Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review. Drug Saf. 2011 Oct 1;34(10):839–847.
  • Alvarez-Requejo A, Carvajal A, Begaud B, et al. Under-reporting of adverse drug reactions estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol. 1998;54(6):483–488.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.